Innovations in Medical Diagnostics Technologies
MedTechONE : Imperial MedTech Links
Innovations in Medical Diagnostics Technologies
Thursday 18th April 1pm- 5:30pm, plus reception from 5:30 onwards.
You are warmly welcomed to attend the latest event in the Imperial MedTech Links series exploring Imperial College innovations in Medical Diagnostics Technologies. Molecular, sequencing, AI and data analytics tools are rapidly changing the world of diagnostics in all disease areas. Hear from Imperial College researchers and clinicians about their work and learn about how we are translating research into products which can be used by clinicians and their patients. We will also let you know about our capabilities and how you might access our laboratories.
Programme (subject to change):
Registration, lunch and Exhibition: 13:00 – 14:00 RSM 3.01 (C, D, E)
Presentations: RSM 2.28
14:00 – 14:10 Welcome and Introduction, Professor George Hanna
Session 1 14:15 – 15:15 RSM 2.28
Molecular Diagnostics
14:15 - 14:30 Dr Sylvain Ladame, Engineering novel screening tools for improving patient stratification in primary care.
14:30 - 14:45 Dr Leah Frenette, Nanozymes for ultrasensitive detection at the point of care.
14:45 - 15:00 Professor Pantelis Georgiou, ProtonDX, Transforming Point-of-Care testing with rapid, affordable, multi-pathogen diagnostics.
15:00 - 15:15 Professor George Hanna, Breath tests to detect gastrointestinal cancers.
Break and exhibition: 15:15 – 15:45 RSM 3.01 (C, D, E)
Session 2 15:45 – 16:30 RSM 2.28
Genomics, sequencing and diagnostics
15:45 - 16:00 Dr David Antcliffe, Diagnostics to monitor the host's response to sepsis.
16:00 - 16:15 Dr Ren Ren, Single Molecule Screening and Diagnostics.
16:15 - 16:30 Regius Professor Chris Toumazou, DnaNudge, Talk title to be confirmed
Session 3 16:30 – 17:30 RSM 2.28
AI and Imperial Capabilities
AI and Diagnostics
16:30 - 16:45 Dr Matthieu Komorowski, Supporting medical decisions with reinforcement learning in the ICU.
16:45 - 17:00 Dr Anand Shah, Opportunities and challenges facing AI in chronic lung disease
17:00 - 17:15 Dr Massimo Micocci, Human Factors studies to support the development of an AI-based technology for skin cancer diagnosis.
Imperial Capabilities
17:15 - 17:30 Dr Florent Seichepine, Laboratory Hire; Dr Peter Buckle, Helping you with regulatory approval; Dr James Choi, MEng Sponsored Projects.
Reception and Exhibition: 17:30 – 18:30 RSM 3.01 (C, D, E)
You can access the programme for this event here: MedTech Links April 2024 programme (PDF)
If you have any questions about this event, please contact:
Robert Ferguson
Industrial Liaison Manager
Dept. of Bioengineering
Imperial College
Email: robert.ferguson@imperial.ac.uk